Beijing, China

Ziping Liu



Average Co-Inventor Count = 13.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Inventor Spotlight: Ziping Liu from Beijing

Introduction

Ziping Liu is a prominent inventor based in Beijing, China, known for his significant contributions to pharmaceutical innovations. With a total of two patents to his name, Liu's work primarily focuses on the development of compounds that target specific medical conditions, particularly in cancer treatment.

Latest Patents

Liu's latest patents revolve around ERK inhibitors. The first patent details a compound of Formula (I), which includes pharmaceutically acceptable salts, esters, and prodrugs that inhibit ERK2. The invention highlights a method for inhibiting ERK2 in patients, involving the administration of an effective amount of the compound. Additionally, it outlines a methodology for treating cancer in patients through similar administration.

The second patent also concerns ERK inhibitors and presents a pharmaceutical composition that comprises an effective amount of the compound and a suitable carrier. This patent further elaborates on the combination of this compound with other active ingredients, which may include chemotherapeutic agents, to enhance treatment effectiveness.

Career Highlights

Throughout his career, Ziping Liu has been associated with renowned companies such as Merck Sharp & Dohme Corporation and MSD R&D (China) Co., Ltd. His experience in these organizations has significantly influenced his research and development endeavors, enabling him to innovate crucial medical therapies.

Collaborations

Liu has collaborated with notable individuals in his field, including coworkers Phieng Siliphaivanh and David L. Sloman. These collaborations reflect his commitment to advancing scientific knowledge and improving patient outcomes through innovative solutions.

Conclusion

Ziping Liu's contributions to the field of pharmaceuticals, particularly through his patents on ERK inhibitors, highlight his role as an instrumental inventor in the healthcare sector. His ongoing work promises to pave the way for future innovations that can significantly impact cancer treatment and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…